SVR24 rates in patients with HCV genotype 5 and 6 infection treated with peginterferon alfa-2a (40KD) plus ribavirin: results from the real world PROPHESYS study

Journal Title: Annals of Hepatology - Year 2014, Vol 13, Issue 2

Abstract

Authors and Affiliations

François D’heygere, Christophe George, Davender Tripathi, Calvin Q. Pan, Jose A. Giron, Manuela Schmitz, Fernando Tatsch

Keywords

Related Articles

Juvenile hemochromatosis associated with heterozygosity for novel hemojuvelin mutations and with unknown cofactors

Background & Aims. Juvenile hemochromatosis (JH) is a rare autosomal recessive disorder characterized by severe early-onset iron overload, caused by mutations in hemojuvelin (HJV), hepcidin (HAMP), or a combi...

Course of a HBsAg positive liver transplantation in a hepatitis B and D virus coinfected recipient

The increasing demand for transplantation has led to consideration of liver grafts from donors exposed to hepatitis B virus (HBV). Six transplantations of liver grafts from hepatitis B surface antigen (HBsAg) positive do...

Adult human liver contains intermediate-type proteasomes with different enzymatic properties

Background. The 20S proteasome is the proteolytic core of the major intracellular protein degradative system, the ubiquitin-proteasome system. Since little is known about proteasomes of human liver, we have investigated...

Spontaneous rupture of a giant non parasitic hepatic cyst presenting as an acute surgical abdomen

Spontaneous rupture of a non parasitic hepatic cyst is an extremely rare occurrence. A 50 -year- old male, was admitted with typical clinical manifestations of acute surgical abdomen. At exploratory laparotomy, a giant r...

A Case Report of Hepatocellular Carcinoma 5 Years After HBsAg Loss in Chronic Hepatitis Delta: How Long Surveillance is Required?

Background. Hepatitis delta virus infection occurs as acute co-infection or as superinfection in patients with preexisting chronic hepatitis B. Chronic hepatitis delta leads to more severe disease than chronic hepatitis...

Download PDF file
  • EP ID EP78389
  • DOI -
  • Views 107
  • Downloads 0

How To Cite

François D’heygere, Christophe George, Davender Tripathi, Calvin Q. Pan, Jose A. Giron, Manuela Schmitz, Fernando Tatsch (2014). SVR24 rates in patients with HCV genotype 5 and 6 infection treated with peginterferon alfa-2a (40KD) plus ribavirin: results from the real world PROPHESYS study. Annals of Hepatology, 13(2), 303-304. https://europub.co.uk/articles/-A-78389